Archives: Speakers

Chan Liu, Comparator Strategist Lead, Pfizer, and Master in Pharmaceuticals, First Military Medical University-Nan Fang Hospital, is a leading expert in clinical supplies across the Asia region, incl. China. Chan is managing sourcing projects for both local, regional and global studies and is responsible for the planning and forecasting of comparator needs, coordination of regulatory reviews, confirmation of label requirements, etc. Furthermore, she has the responsibility for the management of all Pfizer vendors in the region

Philip is an experienced international pharmaceutical executive, having worked for large pharmaceutical companies, biotechnology firms and CROs. He has worked in the industry for 30 years in both International roles and country management. Philip has worked in Europe, USA, Australia, Japan and China where he has resided for the last 14 years. Philip’s extensive knowledge of product development, clinical trials and international business will give some unique insights into the strategies that should be utilized for successful comparator sourcing in the Chinese market.

Martina has held several global leadership roles in ESG strategy, product development and innovation including Senior Vice President, ESG and Engagement Strategy at Moody’s, Global Head of ESG Index Products and Research at S&P DJI, Managing Director of Sustainable Investments Partners Ltd. and Vice President of ESG Solutions at MSCI. Prior to this, she worked in (ESG) product, research and engagement roles at Insight Investment, F&C AM and at Deutsche Bank AG.

Martina has been a member of multiple sustainable finance associations and policy working groups at an EU and an international level. Currently, Martina is part of The Global ESG Leaders Forum – UK/EU/China, the European Law Institute’s Sustainable Finance Advisory Committee, and the Enterprise Data Management Council’s Working Group on ESG Data, Innovation, Technology and Metrics.

Martina is a visiting fellow in sustainable finance at University of Zurich and Henley Business School. She has an MBA certificate in finance and business from LSBF / UK, and a MA in Law and Human Sciences from University of Frankfurt in Germany. She is a fellow member of the Institute for Corporate Responsibility and Sustainability (ICRS) UK, a honorary doctoral fellow of the Institute for Certified Risk Management Professionals (ICRMP) UK, and an alumnus of the German National Academic Foundation (Studienstiftung des Deutschen Volkes).  Martina is a public speaker in sustainable investing and has co-authored a range of ESG and Fintech books, including “The AI Book” (2020).

Alex is the Co-Chief Investment Officer & COO of Goleta Fund SCA SICAV-RAIF, a family of investment funds based in the Grand Duchy of Luxembourg. Having joined the Firm in 2016, he has roles both in the Board of Directors and in the Investment Committee.

As the lead portfolio manager of the Goleta Alternative Fund, our newly launched flagship fund, he was responsible for designing and implementing the strategy of the Goleta Alternative Fund.

Goleta Alternative seeks to provide investors with access to several uncorrelated return streams, aiming to generate long-term alpha, limiting risk and volatility by minimising correlation to traditional financial markets. Not interested in speculative ventures or short-term gains, instead, we look at secular “supertrends” which will shape the future. Accordingly, our objective is to diversify our investments to range from private equity, venture capital, clean energy, healthcare, biotech, ESG projects, technology, real estate, forestry, farmland, and various lending strategies.

An Attorney-at-Law by training, he previously worked began his career with the Mergers and Acquisitions Group at White & Case LLP, a prestigious international law firm based in New York. Having lived in various global cities in Europe, North America, the Middle East and Latin America, he brings to the table an international perspective.

Deepu Joseph is currently serving as the vice president and global head of clinical data management with Quanticate and has over fifteen years experiencing in managing and driving clinical data management operations delivery across major CROs.

Robert brings significant experience onboard in expanding businesses geographically while promoting diversity and inclusion within. He gathered his experience in healthcare, telecommunications, IT and system integration. He worked at companies such as T-Mobile, T-Systems and Philips. As the Global Sales Transformation Leader, Robert successfully designed new business models and drove transformation. Based on his extensive experience, he is a firm believer in teamwork and he is constantly seeking superb team players for RotaChrom. The key to his success is building organizations with strong cultures of commitment, innovation, and drive to overcome challenges while maintaining a positive work environment. He loves spreading great business practices and helping startup ideas to grow and later to scale.

Amanda specialises in developing efficient and effective processes for clinical trial oversight and increasing customer satisfaction. A dynamic professional, Amanda has almost 25 years of operational and commercial experience in the clinical trial industry at both pharmaceutical companies and CROs. She began her career as statistician, moving with time to project management and customer relationship roles.
During her career, Amanda has built and implemented numerous cost-effective solutions for pharmaceutical companies to help them to increase data quality, shorten timelines and reduce costs.
Amanda holds a bachelor’s degree in Statistics from Virginia Polytechnic Institute and State University.